Cannabis is in the spotlight of many debates these days, especially in Pennsylvania where Republican gubernatorial candidate Doug Mastriano is running against Democratic nominee, Attorney General Josh Shapiro.
The Israeli Ministry of Health has approved Y-mAbs Therapeutics’ (NASDAQ: YMAB) lead drug DANYELZA in combination with granulocyte-macrophage colony-stimulating factor for pediatric patients 1 year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow.
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. However, some big-name stocks performed much better than others since the pandemic bottom.
Contrary to 2021, when equity markets were in a bull run, 2022 has served as a not-so-gentle reminder that the stock market does not give free gifts. The macro attitude that is pushing the markets lower has been influenced by worries about a recession, geopolitical tensions, the energy crisis, and record inflation.